ACR 2026 RheumNow PsA Topic Compilation b
From Rheumnow Podcast · · 22 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
BE BOLD Bimekizumab beats Risankizumab in PsA
GLP-1s and Obesity in Rheumatic Disease
BE BOLD with Professor McInnes